Statin use may counter CV risk linked to leuprolide
Statin therapy may attenuate much of the atherogenic effects associated with leuprolide for treatment of prostate cancer, according to a post hoc analysis of the REVELUTION trial published in JACC: CardioOncology. CVD is the leading cause of the death in men with prostate cancer, and adding statin therapy to…